Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeroen Capel

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 10, 2020
ReplyFlorence Wong, Jeroen Capel, Patrick S Kamath
ACG Case Reports Journal|June 10, 2024
Innovative Management of a Difficult Case of Hepatic HydrothoraxNeha Tiwari, Eran Shlomovitz, Jeroen Capel, et al.
Thorax|March 14, 2020
Novel pleural-bladder pump in malignant pleural effusions: from animal model to manPhilippe Astoul, Sophie Laroumagne, Jeroen Capel, et al.
BMC Palliative Care|December 7, 2019
Continuous low flow ascites drainage through the urinary bladder via the Alfapump system in palliative patients with malignant ascitesChristina Fotopoulou, Thomas Berg, Annekristin Hausen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 31, 2020
Improvement in Quality of Life and Decrease in Large-Volume Paracentesis Requirements With the Automated Low-Flow Ascites PumpFlorence Wong, Emily Bendel, Kenneth Sniderman, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 14, 2020
Feasibility and Procedural Safety of alfapump System Implantation by IR: Experience from the MOSAIC Study, a Multicenter, Open-Label Prospective Study in Cirrhotic Patients with Refractory AscitesEmily C Bendel, Kenneth Sniderman, Cathryn Shaw, et al.
The American Journal of Gastroenterology|January 6, 2025
The Effects of Alfapump on Ascites Control and Quality of Life in Patients With Cirrhosis and Recurrent or Refractory AscitesFlorence Wong, Hugo E Vagas, K Rajender Reddy, et al.
BMC Gastroenterology|March 9, 2022
Consensus care recommendations for alfapump<sup>®</sup> in cirrhotic patients with refractory or recurrent ascitesNiels Kristian Aagaard, Massimo Malago, Andrea De Gottardi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 10, 2022
Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pumpGuido Stirnimann, Thomas Berg, Laurent Spahr, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 21, 2018
Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled studyMaria Stepanova, Fatema Nader, Christophe Bureau, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 10, 2020
ReplyFlorence Wong, Jeroen Capel, Patrick S Kamath
ACG Case Reports Journal|June 10, 2024
Innovative Management of a Difficult Case of Hepatic HydrothoraxNeha Tiwari, Eran Shlomovitz, Jeroen Capel, et al.
Thorax|March 14, 2020
Novel pleural-bladder pump in malignant pleural effusions: from animal model to manPhilippe Astoul, Sophie Laroumagne, Jeroen Capel, et al.
BMC Palliative Care|December 7, 2019
Continuous low flow ascites drainage through the urinary bladder via the Alfapump system in palliative patients with malignant ascitesChristina Fotopoulou, Thomas Berg, Annekristin Hausen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 31, 2020
Improvement in Quality of Life and Decrease in Large-Volume Paracentesis Requirements With the Automated Low-Flow Ascites PumpFlorence Wong, Emily Bendel, Kenneth Sniderman, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 14, 2020
Feasibility and Procedural Safety of alfapump System Implantation by IR: Experience from the MOSAIC Study, a Multicenter, Open-Label Prospective Study in Cirrhotic Patients with Refractory AscitesEmily C Bendel, Kenneth Sniderman, Cathryn Shaw, et al.
The American Journal of Gastroenterology|January 6, 2025
The Effects of Alfapump on Ascites Control and Quality of Life in Patients With Cirrhosis and Recurrent or Refractory AscitesFlorence Wong, Hugo E Vagas, K Rajender Reddy, et al.
BMC Gastroenterology|March 9, 2022
Consensus care recommendations for alfapump<sup>®</sup> in cirrhotic patients with refractory or recurrent ascitesNiels Kristian Aagaard, Massimo Malago, Andrea De Gottardi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 10, 2022
Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pumpGuido Stirnimann, Thomas Berg, Laurent Spahr, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 21, 2018
Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled studyMaria Stepanova, Fatema Nader, Christophe Bureau, et al.
Pageof 1